November 4, 2022

Understanding the Efficacy of Phototherapy for Vitiligo

Phototherapy is one of the most effective ways to treat vitiligo. This study analyzed the efficacy of phototherapy in detail, in particular as it relates to combination therapies. When treating patients with vitiligo, healthcare providers can utilize various therapeutic options, including surgical techniques, drugs, and phototherapy. Among the different wavelengths of phototherapy available, narrowband UVB...

A Review of the Efficacy of Inebilizumab In Patients With NMOSD

Inebilizumab, a newly approved medication for NMOSD, is determined to be effective at limiting relapses. However, there are some limitations regarding which patients may benefit. Among patients with neuromyelitis optica spectrum disorder (NMOSD), a significant percentage are anti-aquaporin-4 (AQP4) antibody seropositive. Inebilizumab is a monoclonal antibody treatment that targets the B cell antigen CD19 in...

Understanding the Mechanism of Action of Rituximab in Patients With NMOSD

Rituximab can help patients with NMOSD, but its mechanism is not fully understood. This article explores one possible hypothesis. Neuromyelitis optica spectrum disorders (NMOSD) are autoimmune conditions caused by immunoglobulin G (IgG) autoantibodies directed against the water channel aquaporin-4. Among patients with NMOSD, clinical relapses tend to lead to disability. Relapses can be prevented by...

Vision Loss Variations Among Patients With MS, NMOSD, and MOGAD

Vision loss occurs in patients with MS, NMOSD, and MOGAD, and this study analyzes the different ways and amounts that this occurs. Some patients with neuromyelitis optica spectrum disorders (NMOSD) exhibit optic neuritis (ON), and this can result in more severe vision loss when compared to multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.